Tityus serrulatus scorpion venom induces apoptosis in cervical cancer cell lines

Butantan affiliation
Publication type
Access rights
Open Access
Appears in Collections:
Cervical cancer (CC) is classified as the fourth most common type of cancer in women worldwide and remains a serious public health problem in many underdeveloped countries. Human papillomavirus (HPV), mainly types 16 and 18, has been established as a precursory etiologic agent for this type of cancer. Several therapeutic attempts have been studied and applied, aiming at its control. However, not only do classical treatments such as chemotherapies and radiotherapies target tumor cells, but also they cause damage to several healthy cells. For these reasons, the search for new biologically active chemotherapeutic components is of great importance. In this study, we investigated the effect of Tityus serrulatus scorpion venom (TsV) on CC lines. There are very few studies exploring venom of scorpions, and, to our knowledge, no study has been conducted using the venom of the scorpion TsV for treatment of cervical cancer lines. After challenge with TsV, the MTT assay demonstrated cytotoxic effect on HeLa line. Similarly, the cell death process in HeLa analyzed by flow cytometry suggests death via caspase, since the pan-caspase inhibitor z-VAD-fmk significantly reduced the apoptotic response to the treatment. These results suggest that venom of TsV can be a potential source for the isolation of effective antiproliferative and apoptotic molecules in the treatment of CC.
Bernades-Oliveira E, Farias KJS, Gomes DL, Araújo JMG, Silva WD, Rocha HAO, et al. Tityus serrulatus scorpion venom induces apoptosis in cervical cancer cell lines. Adv. Neurosci.. 2019 Jun;2019:5131042. doi:10.1155/2019/5131042.
Link to cite this reference
Issue Date

Files in This Item:

Existing users please Login
Size: 3.23 MB
Format: Adobe PDF
Embargoed until January 1, 2999    Request a copy
Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.